Hepatocellular Carcinoma (HCC) Surveillance Biomarker Landscape Overview

Description

Supported by: FUJIFILM Healthcare Americas Corporation

CC surveillance is associated with reduced HCC mortality. However, ultrasound has insufficient sensitivity for early tumor detection, prompting increasing interest in blood-based biomarkers. In this session, we will review the phases of biomarker validation, present the status and data for (protein and liquid biopsy) biomarkers, and discuss ongoing biomarker studies.

Moderator:  

Laura M. Kulik, MD

Presenters:

Professor Amit Singal, MD, MS

Professor Neehar Parikh, MD, MS